Marco Caminati Francesco Menzella Lucia Guidolin Gianenrico Senna
10.7573/dic.212587
Drugs Context
2019 Jul 23;8:212587.
abpa egpa benralizumab eosinophilic esophagitis eosinophilic inflammation mepolizumab reslizumab severe asthma
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/31391853/
Review
PMC6668506
31391853
Targeting eosinophils: severe asthma and beyond
2019